Cite
HARVARD Citation
Wu, L. et al. (2022). Efficacy and safety of S-1 based adjuvant chemoradiotherapy for resected pancreatic ductal adenocarcinoma with high-risk pathological feature: a prospective, single-arm, interventional study. Journal of pancreatology. 5 (1), pp. 18-26. [Online].